KAPPA-TYPE OPIOID RECEPTOR

Approval Year

Substance Class	Protein Created by `admin` on `Thu Jul 06 17:41:23 UTC 2023` Edited by `admin` on `Thu Jul 06 17:41:23 UTC 2023`
Protein Type	RECEPTOR
Protein Sub Type	OPIOID RECEPTOR
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	2BJ58BX78W
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

KAPPA-TYPE OPIOID RECEPTOR

Common Name

English

OPRK1

Common Name

English

OPRK

Common Name

English

κ-Opioid Receptor

Common Name

English

K-OR-1

Common Name

English

Code System Code Type Description

FDA UNII

2BJ58BX78W

Created by admin on Thu Jul 06 17:41:27 UTC 2023 , Edited by admin on Thu Jul 06 17:41:27 UTC 2023

PRIMARY

PHAROS

P41145

Created by admin on Thu Jul 06 17:41:27 UTC 2023 , Edited by admin on Thu Jul 06 17:41:27 UTC 2023

PRIMARY

UNIPROT

P41145

Created by admin on Thu Jul 06 17:41:27 UTC 2023 , Edited by admin on Thu Jul 06 17:41:27 UTC 2023

PRIMARY

From	To
1_131	1_210

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_25
N	1_39

Related Record Type Details


					677C126AET

ALVIMOPAN

AGONIST -> TARGET

Amount:


					FDR3CJ69GC

Bremazocine, (-)-

AGONIST -> TARGET

Amount:


					7ATC8US66S

BW-942C

PARTIAL AGONIST->TARGET


					VC8MB066E2

FEKAP C-11

TARGET->RADIOLIGAND

Qualification:

Amount:


					KUE3ZY3J1F

BENZAMIDINE

INHIBITOR -> TARGET


					5S6W795CQM

NALTREXONE

INHIBITOR -> TARGET


					J5S4K6TKTG

U-69593

AGONIST -> TARGET

Comments:

[35S]-GTPγS Assay Emax

Qualification:

EC50

Amount:


					03KSI6WLXH

NALDEMEDINE

INHIBITOR -> TARGET


					T56W91NG6J

SALVINORIN A

AGONIST -> TARGET

Qualification:

Amount:


					1F0L5N25ZZ

DIPRENORPHINE

INHIBITOR -> TARGET

Comments:

Assumed Kd similar to all opioid receptors

Qualification:

Amount:


					W9PNL4KR4L

TIFLUADOM, (R)-

AGONIST -> TARGET

Qualification:

Amount:


					6IO4IG518S

KETAZOCINE

AGONIST -> TARGET

Comments:

Mouse tail test.

Qualification:

ED50

Amount:


					DE4G8X55F5

ATICAPRANT

INHIBITOR -> TARGET


					MQS88P23Q4

NALDEMEDINE-CARBOXYLIC ACID

INHIBITOR -> TARGET


					CVL1MSR5Z2

CMX-020

AGONIST -> TARGET


					XK5ILZ28KI

Navacaprant

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					X2J2P6LVB6

EKAP

RADIOLIGAND->TARGET

Qualification:

Amount:


					MWN7742MT4

LY-2459989 F-18

RADIOLIGAND->TARGET


					D343S4VX5G

THIOBROMADOL

NON-INHIBITOR->OFF TARGET

Amount:


					7GDW9S3GN3

CEBRANOPADOL

AGONIST -> TARGET

Amount:


					XC41AVD567

NALFURAFINE

AGONIST -> TARGET

Amount:


					NA1U919MRO

DIFELIKEFALIN

AGONIST -> TARGET

Amount:


					Q5R50X7L6M

ICI-199441

AGONIST -> TARGET


					L2T84IQI2K

NALBUPHINE

AGONIST -> TARGET

Amount:


					6YTL4W7ABA

CYX-6

INHIBITOR -> TARGET

Amount:


					22SCY98BXV

Anrikefon

AGONIST -> TARGET

Amount:


					39K8JHE8XN

U-50488

AGONIST -> TARGET

Comments:

Selective for the kappa receptor no mu activity.

Amount:


					VC8MB066E2

FEKAP C-11

RADIOLIGAND->TARGET

Qualification:

Amount:


					8PEV67L3NU

TIFLUADOM, (S)-

AGONIST -> TARGET

Amount:


					A2G9VU2P2J

PENTAZOCINE, (+)-

AGONIST -> TARGET

Amount:


					UF599785JZ

FENTANYL

NON-INHIBITOR->OFF TARGET

Amount:


					D0VK52NV5M

ASIMADOLINE

AGONIST -> TARGET

Qualification:

IC50

Amount:


					C9C204973M

3-METHYLTHIOFENTANYL

AGONIST -> TARGET

Amount:


					76I7G6D29C

MORPHINE

AGONIST -> TARGET

Qualification:

Amount:


					CD35PMG570

OXYCODONE

AGONIST -> TARGET


					7W2581Z5L8

SAMIDORPHAN

PARTIAL AGONIST->TARGET


					CSJ43DHV6P

NALDEMEDINE 3-O-.BETA.-D-GLUCURONIDE

INHIBITOR -> TARGET


					OLU0LZA3MM

LY-2459989 C-11

RADIOLIGAND->TARGET


					LK97CY7UA6

NALDEMEDINE 6-O-.BETA.-D-GLUCURONIDE

INHIBITOR -> TARGET


					DUK8PZ84YX

NOR-NALDEMEDINE

INHIBITOR -> TARGET


					QV897JC36D

BUTORPHANOL

AGONIST -> TARGET


					2SEC01B703

DERMORPHIN

NON-INHIBITOR->OFF TARGET

Amount:


					QVU94XE61A

3-METHYLFENTANYL

AGONIST -> TARGET

Amount:


					7GDW9S3GN3

CEBRANOPADOL

TARGET -> AGONIST


					GH7ZNH3JMF

RB-64

AGONIST -> TARGET

Amount:


					2X23M5HP34

LY-2459989

LIGAND->TARGET


					2U8R7MKP30

FEKAP

TARGET->RADIOLIGAND

Qualification:

Amount:


					NT43S9BKJ2

AT-076

INHIBITOR -> TARGET

Interaction Type:

ANTAGONIST


					ISF76M2DBE

BREMAZOCINE

AGONIST -> TARGET

Comments:

A potent analgesic with a low dependence liability and with no respiratory depressant effects in preliminary pharmacologic screening.

Qualification:

Amount:


					36OOQ86QM1

NORBINALTORPHIMINE

INHIBITOR -> TARGET


					6IY4WX208T

U-47700

WEAK AGONIST->TARGET

Qualification:

EC50

Amount:


					40D3SCR4GZ

BUPRENORPHINE

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

Amount:


					3C6FZ6UXC8

JDTIC

AGONIST -> TARGET

Amount:


					RP4A60D26L

PENTAZOCINE

AGONIST -> TARGET

Amount:


					TF8X866L0I

Tifluadom

AGONIST -> TARGET

Qualification:

Amount:


					ZRY1A3U534

EKAP C-11

RADIOLIGAND->TARGET

Qualification:

Amount:


					45TPJ4MBQ1

ELUXADOLINE

AGONIST -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT	CHEMICAL